Hepatitis, Autoimmune: Clinical Trials

8 trials for Hepatitis, Autoimmune, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown, 3 completed. 8 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 48Unknown 5, Completed 3

Follow Hepatitis, Autoimmune: new trials by email Literature Review of Hepatitis, Autoimmune trials Research Report on Hepatitis, Autoimmune

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tacrolimus Versus Mycophenolate for Autoimmune Hepatitis Patients With Incomplete Response on First Line Therapy
Mycophenolate Mofetil, Tacrolimus - Autoimmune Hepatitis
Phase 4UnknownLeiden University Medical Center862022-01-192022-02-03
A Randomised Clinical Trial Assessing the Efficacy and Safety of Mycophenolate Mofetil Versus Azathioprine for Induction of Remission in Treatment Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome
Methylprednisolone and Mycophenolate mofetil, Methylprednisolone and azathioprine - Autoimmune Hepatitis, Primary Biliary Cirrhosis
Phase 4UnknownXiaoli Fan782021-06-162021-06-21
Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy
Cyclosporin A, Mycophenolate Mofetil - Hepatitis, Autoimmune, Primary Biliary Cholangitis
Phase 4UnknownWest China Hospital892021-06-162021-06-22
Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II
Ursodeoxycholic acid, Ursodeoxycholic acid+Low Dose Glucocorticoid(Methylprednisolone) - Hepatitis, Autoimmune, Primary Biliary Cholangitis
Phase 4UnknownWest China Hospital902020-11-012021-03-22
Mycophenolate Mofetil Versus Azathioprine in Treatment Naive Autoimmune Hepatitis
Mycophenolate mofetil, Azathioprine - Autoimmune Hepatitis
Phase 4UnknownRadboud University Medical Center702017-01-012023-06-22
Possible Role of Chloroquine to Induce a Complete Remission in the Treatment of Autoimmune Hepatitis: a Randomized Trial
Chloroquine diphosphate, prednisone, azathioprine - Autoimmune Hepatitis
Phase 4CompletedUniversity of Sao Paulo General Hospital572003-05-012017-02-15
CHLOROQUINE FOR MAINTENANCE REMISSION OF AUTOIMMUNE HEPATITIS
Chloroquine diphosphate 250mg, Placebo - Hepatitis, Autoimmune
Phase 4CompletedUniversity of Sao Paulo General Hospital612002-02-012016-10-26
Mycophenolate vs Azathioprin in Autoimmune Hepatitis
Treatment with mycophenolat mofetil, Treatment with azathioprin - Autoimmune Hepatitis
Phase 4CompletedCopenhagen University Hospital, Rigshospitalet2008-05-30

Narrower conditions

Liver Cirrhosis, Biliary (3)  ·  Recurrence (1)

Broader conditions

Autoimmune Diseases (8)  ·  Digestive System Diseases (8)  ·  Hepatitis (8)  ·  Hepatitis, Chronic (8)  ·  Immune System Diseases (8)  ·  Liver Diseases (8)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Bile Duct Diseases (3)  ·  Biliary Tract Diseases (3)  ·  Cholestasis (3)  ·  Cholestasis, Intrahepatic (3)  ·  Fibrosis (3)  ·  Liver Cirrhosis (3)  ·  Disease Attributes (1)

Interventions

Mycophenolic Acid (4)  ·  Azathioprine (3)  ·  chloroquine diphosphate (2)  ·  Chloroquine (1)  ·  Cyclosporine (1)  ·  Methylprednisolone (1)  ·  Prednisone (1)  ·  Tacrolimus (1)  ·  Therapeutics (1)  ·  Ursodeoxycholic Acid (1)

Sponsors

University of Sao Paulo General Hospital (2)  ·  West China Hospital (2)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Leiden University Medical Center (1)  ·  Radboud University Medical Center (1)  ·  Xiaoli Fan (1)

Countries

China (3)  ·  Netherlands (2)  ·  Belgium (1)  ·  Brazil (1)  ·  Denmark (1)

Top investigators

Bart van Hoek (1)  ·  Bart van Hoek, MD, PhD (1)  ·  Joost PH Drenth, MD, PhD (1)

Results publications

PMID 32514439, PMID 38101756, PMID 38233878